Last updated at 27 Jun 2024 09:17 PM
Director
DIN: 06802248
Sourabh Gandhi is currently associated with 3 companies in various capacities such as Designated Partner and Director. They serve as a Director at ADELSON PHARMACEUTICALS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06802248.Sourabh Gandhi has previously been associated with 2 companies in roles such as Director and Additional Director.Sourabh Gandhi is currently involved in 2 different roles. Their most recent position is with CUSAK PHARMA PRIVATE LIMITED as a Director. The first company Sourabh Gandhi was appointed to as a director was ADELSON PHARMACEUTICALS LLP. Sourabh Gandhi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sourabh Gandhi is currently associated with 3 companies in various capacities such as Designated Partner and Director. They serve as a Director at ADELSON PHARMACEUTICALS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06802248.Sourabh Gandhi has previously been associated with 2 companies in roles such as Director and Additional Director.Sourabh Gandhi is currently involved in 2 different roles. Their most recent position is with CUSAK PHARMA PRIVATE LIMITED as a Director. The first company Sourabh Gandhi was appointed to as a director was ADELSON PHARMACEUTICALS LLP. Sourabh Gandhi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (2)
2y 5m 1y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| JISARA LIFESCIENCE PRIVATE LIMITED | Director | 19-Dec-2014 |
| CUSAK PHARMA PRIVATE LIMITED | Director | 31-Dec-2019 |